#36 Pediatric Neurology

Guest: Josh Bonkowsky, MD, PhD

December 2021

 

SUBSCRIBE:

Listen on Google Play Music

Show Notes

Disclosures

A grant from Primary Children’s Hospital is associated with this CME activity. They have no influence over the speakers or content.

 

Disclosure of Financial Relationships and Resolution of Conflicts of Interest for KAAP CME Activities

The KAAP CME program develops, maintains, and improves the competence, skills, and professional performance of pediatricians and pediatric healthcare professionals by providing quality, relevant, accessible, and effective educational experiences that address gaps in professional practice.  The KAAP CME program strives to meet the educational needs of pediatricians and pediatric healthcare professionals and support their lifelong learning with a goal of improving care for children and families.  

KAAP recognizes that there are a variety of financial relationships between individuals and commercial interests that require review to identify possible conflicts of interest in a CME activity. KAAP strives to ensure quality, objective, balanced, and scientifically rigorous CME activities by identifying and resolving all potential conflicts of interest prior to the confirmation of service of those in a position to influence and/or control CME content. KAAP has taken steps to resolve any potential conflicts of interest.

All KAAP CME activities will strictly adhere to the Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support: Standards to Ensure the Independence of CME Activities. In accordance with these Standards, the following decisions will be made free of the control of a commercial interest: identification of CME needs, determination of educational objectives, selection and presentation of content, selection of all persons and organizations that will be in a position to control the content, selection of educational methods, and evaluation of the CME activity.

The purpose of this policy is to ensure all potential conflicts of interest are identified and mechanisms to resolve them prior to the CME activity are implemented in ways that are consistent with the public good. KAAP is committed to providing learners with commercially unbiased CME activities.

DISCLOSURE OF FINANCIAL RELATIONSHIPS

All individuals in a position to influence and/or control the content of CME activities are required to disclose to KAAP and subsequently to learners that the individual either has no relevant financial relationships or any financial relationships with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services discussed in CME activities.  Listed below are the disclosures provided by individuals in a position to influence and/or control CME activity content.  

* A commercial interest is defined as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients.   

 

Disclosure of Commercial Support for AAP CME Activities

A grant from Primary Children’s Hospital is associated with this CME activity. They have no influence over the speakers or content.

Name Role

Relevant Financial Relationship

(Please indicate Yes or No)

Name of Commercial Interest(s)*

Please list name(s) of entity

AND

Nature of Relevant Financial Relationship(s)

(Please list: Research Grant, Speaker’s Bureau, Stock/Bonds excluding mutual funds, Consultant, Other – identify)

Disclosure of Off-Label (Unapproved)/Investigational Uses of Products
AAP CME faculty are required to disclose to the AAP and to learners when they plan to discuss or demonstrate pharmaceuticals and/or medical devices that are not approved by the FDA and/or medical or surgical procedures that involve an unapproved or “off-label” use of an approved device or pharmaceutical.

(Do intend to discuss or Do not intend to discuss)

Paul Wirkus Planner/Moderator NO NONE Do not intend to discuss
Josh Bonkowsky Faculty YES

Consultant:

Bluebird Bio (5/2017; 10/2017; 11/2019)

Calico (1/2018-present)

Denali therapeutics (6/2019)

Enzyvant (6/2019)

Neurogene (3/2020-current)

Passage Bio (6/2020- current)

Takeda (8/2020)

Autobahn (10/2020- current)

Grants

NIH CTSA 7/2018- 2/2019

NIH NINDS 12/2018-current

Clinical Trials

Shire/Takeda 12/2020-present

SwanBio 9/2021-present

Passage Bio 9/2021- present

Board of Directors

wfluidx 1/2018-present

Stock

Orchard Therapeutics

Royalties

BioFire (spouse) 6/2016- present

Manson publishing 1/2015- present

Writing content

UpToDate 9/2021- present

Do not intend to discuss
Carolyn Reynolds Planner NO NONE Do not intend to discuss
Alisa Stoddard UTAAP Staff/COI Reviewer-Resolver NO NONE Do not intend to discuss

ACCME Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Colorado Medical Society through the joint providership of Kansas Chapter, American Academy of Pediatrics and Utah Chapter, AAP.  Kansas Chapter, American Academy of Pediatrics is accredited by the Colorado Medical Society to provide continuing medical education for physicians.

 

AMA Credit Designation Statement

Kansas Chapter, American Academy of Pediatrics designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Guest: Josh Bonkowsky, MD

Quiz available after 4th episode airs, typically the fourth week of the month.

Virtual Curbside Podcast – Pediatric Neurology
Dates valid for credit: August 23, 2033 – August 23, 2025

Claim for Credit

  • Learners who complete the activity are eligible for 1.0 AMA PRA Category 1 Credit TM.
  • Learners who complete all quiz questions, and who meet the 50% minimum passing score requirements, will be eligible for 1.0 MOC Part 2 points.

Learning Objectives

After listening to these episodes listeners will…

  • Options for referring patients for pediatric neurology care
  • Distinguish options for how best to consult regarding a patient
  • Learn the new options in genetic testing and genetic therapies

Acknowledgements

Written and Hosted by: Paul Wirkus, MD, FAAP
Administrator/Producer/Photographer: Alisa Stoddard, UTAAP Executive Director
Audio Engineer: Alisa Stoddard
Music by: Phil Wirkus
Guest: Josh Bonkowsky, MD, PhD

Questions?  Send us an email.